Thus, anti-TNF-α monoclonal antibodies are broadly used and are efficient in particular for the treatment of rheumatoid arthritis (RA), inflammatory bowel disease (IBD), psoriasis, psoriatic arthritis, ankylosing spondylitis (AS), and juvenile idiopathic arthritis (JIA) [2]. The gene discussed is TNF; the disease is inflammatory bowel disease.